MoonLake Immunotherapeutics
NASDAQ:MLTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Shareholder Yield
Current shareholder yield for MLTX is .
Peers Comparison
Shareholder Yield
Price Appreciation
MLTX Price
MoonLake Immunotherapeutics
| Average Annual Return | 76.56% |
| Standard Deviation of Annual Returns | 224.99% |
| Max Drawdown | -90% |
| Market Capitalization | 964m USD |
| Shares Outstanding | 82 630 000 |
| Percentage of Shares Shorted | 12.69% |